Every filing, one decision per row.

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Companies 1/25
Result 139 decisions over 120 months
Reset filters
Minimum amount ? Share of their own holding ?
What the chief executive holds ?
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
28 Aug 2026
President & Immunovant CEO
Sold on a plan
200,000
$7.15M
11.1%
21 Aug 2026
President & CIO
Sold at will
144,756
$5.28M
0.8%
19 Aug 2026
President & CIO
Sold at will
172,899
$6.43M
0.9%
18 Aug 2026
President & CIO
Sold at will
136,942
$5.03M
0.7%
17 Aug 2026
President & CIO
Sold at will
284,707
$10.32M
1.5%
14 Aug 2026
President & CIO
Sold at will
243,177
$8.81M
1.3%
27 Jul 2026
President & Immunovant CEO
Sold on a plan
200,000
$6.99M
11.0%
30 Jun 2026
Director
Sold at will
200,000
$7.09M
10.3%
29 Jun 2026
Director indirect
Sold at will
800,000
$27.64M
5.5%
29 Jun 2026
Director by Deputization indirect
Sold at will
800,000
$27.64M
5.5%
29 Jun 2026
Director indirect
Sold at will
800,000
$27.64M
5.5%
26 Jun 2026
Director by Deputization indirect
Sold at will
625,783
$21.28M
4.1%
26 Jun 2026
Director indirect
Sold at will
625,783
$21.28M
4.1%
26 Jun 2026
Director indirect
Sold at will
625,783
$21.28M
4.1%
26 Jun 2026
President & CIO
Sold at will
500,000
$17.04M
2.6%
25 Jun 2026
President & CIO
Sold at will
500,000
$17.07M
2.6%
24 Jun 2026
President & Immunovant CEO
Sold on a plan
200,000
$6.63M
11.0%
22 May 2026
President & Immunovant CEO
Sold on a plan
200,000
$6.05M
11.0%
20 Apr 2026
President & Immunovant CEO
Sold on a plan
200,000
$5.92M
10.8%
16 Apr 2026
CEO
Sold at will
289,774
$8.45M
1.7%
26 Mar 2026
Director
Sold at will
70,000
$1.92M
62.0%
17 Mar 2026
President & Immunovant CEO
Sold on a plan
200,000
$5.65M
10.8%
16 Mar 2026
Director
Sold at will
41,861
$1.20M
72.6%
23 Feb 2026
President and Vant Chair
Sold on a plan
587,390
$16.16M
4.1%
20 Feb 2026
President and Vant Chair
Sold on a plan
1,012,610
$27.49M
6.9%
19 Feb 2026
President and Vant Chair
Sold on a plan
1,400,000
$38.39M
9.2%
13 Feb 2026
Director by Deputization indirect
Sold at will
375,784
$9.96M
2.4%
13 Feb 2026
Director indirect
Sold at will
375,784
$9.96M
2.4%
13 Feb 2026
Director indirect
Sold at will
375,784
$9.96M
2.4%
13 Feb 2026
President & Immunovant CEO
Sold on a plan
200,000
$5.30M
10.8%
12 Feb 2026
Director indirect
Sold at will
425,000
$11.37M
2.7%
12 Feb 2026
Director by Deputization indirect
Sold at will
425,000
$11.37M
2.7%
12 Feb 2026
Director indirect
Sold at will
425,000
$11.37M
2.7%
11 Feb 2026
Director indirect
Sold at will
425,000
$11.33M
2.6%
11 Feb 2026
Director by Deputization indirect
Sold at will
425,000
$11.33M
2.6%
11 Feb 2026
Director indirect
Sold at will
425,000
$11.33M
2.6%
9 Feb 2026
President & CIO
Sold at will
339,441
$8.99M
1.7%
12 Jan 2026
President & Immunovant CEO
Sold on a plan
200,000
$4.38M
10.8%
31 Dec 2025
President & CIO
Sold at will
1,018,995
$22.12M
4.8%
29 Dec 2025
President & CIO
Sold at will
311,873
$6.78M
1.6%
24 Dec 2025
President & Immunovant CEO
Sold at will
75,000
$1.69M
4.3%
23 Dec 2025
CFO
Sold at will
406,731
$9.12M
62.9%
23 Dec 2025
President & Immunovant CEO
Sold at will
200,000
$4.49M
11.0%
17 Dec 2025
Director indirect
Sold at will
777,332
$17.94M
4.5%
17 Dec 2025
Director indirect
Sold at will
777,332
$17.94M
4.5%
17 Dec 2025
Director by Deputization indirect
Sold at will
777,332
$17.94M
4.5%
16 Dec 2025
Director indirect
Sold at will
917,282
$21.13M
5.1%
16 Dec 2025
Director indirect
Sold at will
917,282
$21.13M
5.1%
16 Dec 2025
Director by Deputization indirect
Sold at will
917,282
$21.13M
5.1%
15 Dec 2025
CEO
Sold at will
1,740,000
$37.72M
9.1%
Showing 1–50 of 139. Page 1 of 3 Older →